<DOC>
	<DOC>NCT02260089</DOC>
	<brief_summary>To evaluate the efficacy and tolerability of telmisartan, given once a day to patients with mild to moderate hypertension, as well as to assess the 24-hour blood pressure profile with ABPM</brief_summary>
	<brief_title>Telmisartan in Mild to Moderate Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Patients with blood pressure levels of 140/90 mm Hg or higher (confirmed on 2 consecutive visits), who were 18 years old and older, regardless of sex Suspected or known diagnosis of arterial hypertension with a secondary cause Women who were not using an effective method of contraception, or who were pregnant, or breastfeeding Systolic blood pressure &gt; 200 mm Hg or diastolic blood pressure &gt; 115 mm Hg Laboratory test values two fold above the upper normal limit Previous intolerance to angiotensin conversion enzyme inhibitors or angiotensin II blocker (AIIAR) New York Heart Association class III or IV heart failure History of stroke in the 6 months prior to entry into the study Uncontrolled type 2 diabetes mellitus, defined as fasting glucose levels &gt; 140 mg/dL on 3 consecutive assessments Patients who were included in another investigational drug study in the past 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>